Free Trial
ASX:AC8

AusCann Group (AC8) Stock Price, News & Analysis

About AusCann Group Stock (ASX:AC8)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
537,446 shs
Average Volume
N/A
Market Capitalization
A$17.62 million
P/E Ratio
N/A
Dividend Yield
6.79%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AC8 Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AusCann Group and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AC8 Stock News Headlines

AusCann Group Holdings Ltd (ACNNF)
BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. tc pixel
AC8.AX - AusCann Group Holdings Ltd
ACNNF AusCann Group Holdings Ltd
See More Headlines

AC8 Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that AusCann Group investors own include 3D Systems (DDD), Bristol Myers Squibb (BMY), Johnson & Johnson (JNJ), Workday (WDAY), Zoom Communications (ZM), Zynerba Pharmaceuticals (ZYNE) and Ambarella (AMBA).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
ASX:AC8
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$9.44 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-1.09%
Return on Assets
-1.67%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
33.22
Quick Ratio
20.17

Sales & Book Value

Annual Sales
A$1.36 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
2.05
Book Value
A$0.01 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
440,550,000
Free Float
N/A
Market Cap
A$17.62 million
Optionable
Not Optionable
Beta
0.72
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (ASX:AC8) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners